NCT05880927 Pyrotinib After Trastuzumab-based Adjuvant Therapy in Patients With HER2-positive Breast Cancer Status RECRUITING Phase PHASE2
NCT05879926 Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25 Status RECRUITING Phase PHASE3
NCT05878964 Evaluation of Skin Health and QoL in Pts Receiving Anti-PD1/PDL1/CTLA4 or CDK Inhibitors. Status RECRUITING Phase N/A
NCT05878678 Prospective Study of Particle Radiotherapy for Breast Cancer With Different Arm Position Status UNKNOWN Phase PHASE2
NCT05878106 Creatine Supplementation and Resistance Training in Patients With Breast Cancer Status RECRUITING Phase NA
NCT05877599 A Study of NT-175 in Adult Subjects With Unresectable, Advanced, and/or Metastatic Solid Tumors That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation Status RECRUITING Phase PHASE1
NCT05876728 Role of Irisin/FNDC5 (rs3480) Single Nucleotide Polymorphism in Breast Cancer Status UNKNOWN Phase N/A
NCT05876390 Impact of Regional Anesthesia on Chronic Post-operative Pain Status ENROLLING_BY_INVITATION Phase N/A
NCT05874492 Evaluation of the Medical Benefit of Spa Therapy on Fibrosis After Radiotherapy for Breast Cancer or UADT (Upper Aerodigestive Tract) Cancer Status RECRUITING Phase NA
NCT05873036 Comparison of AT & PR Training to Improve Functional Ability After Breast Cancer Surgery Status UNKNOWN Phase NA
NCT05871437 Randomized Controlled Clinical Study on the Reduction of Tumor Marker Levels in Breast Cancer Patients by Huaier Granules Status NOT_YET_RECRUITING Phase PHASE4
NCT05871125 Identifying Ideal Reimbursement "Dose" to Reduce Clinical Trial-related Financial Toxicity Status COMPLETED Phase NA
NCT05871008 Integrated Actionable Aging Assessment for Cancer Patients Pilot Status ACTIVE_NOT_RECRUITING Phase NA
NCT05870813 CLEAR-B: Cancer Landscape - Early Adjuvant Retrospective Registry - Breast Cancer Status UNKNOWN Phase N/A
NCT05870579 [177Lu]Lu-NeoB in Combination With Ribociclib and Fulvestrant in Participants With ER+, HER2- and GRPR+ Advanced Breast Cancer Status RECRUITING Phase PHASE1
NCT05868746 An Observational Pilot Study to Test a Smartwatch-based EMA Method During Exercise With Breast Cancer Survivors Status COMPLETED Phase N/A
NCT05866458 Radiation OmisSion in PAtients With CLinically Node Negative Breast Cancer Undergoing Lumpectomy Status RECRUITING Phase N/A